Source: Tsai and Gu Addict Sci Clin Pract (2019) 14:9 https://doi.org/10.1186/s13722-019-0138-4 Abstract Background The high prevalence of substance use disorders (SUDs) among incarcerated adults in the U.S. is well-known, but there has been less examination of SUD treatment and rates of...
Abstract This study evaluates the use of a mental health mobile clinic to overcome two major challenges to the provision of mental healthcare in resource-limited settings: the shortage of trained specialists; and the need to improve access to safe, effective, and culturally sound care in community...
"Molecular Imaging in SUD: Opportunities for Translation into Basic and Clinical Neuroscience" from the Cellular Biology of Drug Addiction course 8/9/2013
A number of treatments can help smokers make a successful quit attempt, but many initially successful quitters relapse over time. Several interventions have been proposed to help prevent relapse. A recent study has examined whether specific interventions for relapse prevention reduce the proportion...
Kosten, T. R., & Baxter, L. E. (2019). Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. The American journal on addictions.doi: 10.1111/ajad.12862
Message from an amalgamation of research findings for the American Psychological Association is that conveying genuineness and authenticity - at least during therapy, being and giving of yourself as an integrated character - is one way therapists underpin an effective therapeutic relationship. But what if a therapy’s mandates demand a less than genuine response?
Online and open access Ekendahl, Mats, Josefin Månsson, and Patrik Karlsson. "Risk and responsibilization: resistance and compliance in Swedish treatment for youth cannabis use." Drugs: Education, Prevention and Policy (2018): 1-9.
The purpose of this survey is to seek your opinions on areas for the treatment of substance use disorder due to methamphetamine and other emerging drugs of concern that would benefit from the conduct of clinical research.
Emerging drugs of concern include new drugs appearing in the market and known drugs of emerging concern, that are causing harm, or have the potential to have a population health impact.
For the purposes of this survey, clinical research is intervention focused and conducted in a range of community and health care settings by a range of different health professionals.
This webcast, Why addiction is a “disease” and why it’s important, defines what is a disease and why it is important to emphasize addiction/substance use disorder (SUD) as a brain disease from a neurobiological perspective as well as from a biopsychosocial perspective. Discussion will also include...
At the county-level, an additional Substance Abuse Treatment (SAT) facility reduces drug-related mortality by 0.50% annually, and municipal felony-type crimes by 0.10 % annually, according to the authors. This publication provides support for the idea that there are broad-based benefits of SAT...
Abstract Background Systematic efforts to improve the quality, safety and value of health care have increased over the last decades. Even so, it is hard to choose priorities and to know when the desired results are reached, especially in forensic psychiatric care where there can be a discrepancy...
CBS: Dr. Nora Volkow, the head of the National Institute on Drug Abuse, has revolutionized how science and medicine view addiction: as a disease, not a character defect. Morley Safer reports.
This webinar is part of the NIDA CTN's "Using Mobile Technologies in the CTN" series. Find more information, and links to the other webinars in the series, here: http://ctndisseminationlibrary.org/display/1173.htm
This website offers resources developed from a two-year research programme on end of life care for people with alcohol and other drug problems. The research programme was the first of its kind to explore current practice and service experience from a range of perspectives.
The findings have been used to develop information and resources on how best to support people with substance use problems, or how substance use services can support people with serious and life-limiting conditions.
Degenhardt, L., Glantz, M., Evans‐Lacko, S., Sadikova, E., Sampson, N., Thornicroft, G., … Zaslavsky, A. M. (2017). Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys. World Psychiatry, 16(3), 299–307. http://doi.org/10.1002/wps.20457
Abstract
Substance use is a major cause of disability globally. This has been recognized in the recent United Nations Sustainable Development Goals (SDGs), in which treatment coverage for substance use disorders is identified as one of the indicators. There have been no estimates of this treatment coverage cross-nationally, making it difficult to know what is the baseline for that SDG target. Here we report data from the World Health Organization (WHO)'s World Mental Health Surveys (WMHS), based on representative community household surveys in 26 countries. We assessed the 12-month prevalence...
Since the 1930s, the response to drug addiction has moved from one that focuses on the need to punish users to another that recognises the importance of prevention and treatment approaches.
In other words, thanks to scientific advances, substance abuse has evolved from a judicial to a heath issue.
Drawing on the latest evidence-based knowledge, Drugs, Brains and Behavior: The Science of Addiction, a new publication from the National Institute on Drug Abuse (NIDA), looks to explain why people become dependent on drugs, as well as how changes in the brain can foster drug addiction.